Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF10A antibody

The Mouse Monoclonal anti-TNFRSF10A antibody (Clone TR1-02) (ABIN1169238) specifically detects TNFRSF10A in FACS and IHC. The antibody is reactive with Human samples.
Catalog No. ABIN1169238
-20% for 20 Years of ABO
$465.75
$582.19
save $116.44 (-20 %)
Plus shipping costs $50.00
Shipping to: United States
Delivery in 5 to 10 Business Days

Quick Overview for TNFRSF10A antibody (ABIN1169238)

Target

See all TNFRSF10A Antibodies
TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))

Reactivity

  • 108
  • 17
  • 16
  • 1
  • 1
Human

Host

  • 64
  • 39
  • 5
Mouse

Clonality

  • 66
  • 42
Monoclonal

Conjugate

  • 47
  • 11
  • 8
  • 7
  • 7
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TNFRSF10A antibody is un-conjugated

Application

  • 58
  • 31
  • 28
  • 26
  • 23
  • 19
  • 13
  • 8
  • 5
  • 5
  • 2
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (IHC)

Clone

TR1-02
  • Purpose

    anti-TRAIL-R1 (human), mAb (TR1.02)

    Specificity

    Recognizes human TRAIL-R1. Does not cross-react with human TRAIL-R2, -R3 or -R4.

    Cross-Reactivity (Details)

    Does not cross-react with human TRAIL-R2, -R3 or -R4.

    Characteristics

    Monoclonal Antibody. Recognizes human TRAIL-R1. Does not cross-react with human TRAIL-R2, -R3 or -R4. Isotype: Mouse IgG2b. Clone: TR1.02. Applications: FACS, IHC. Liquid. In PBS containing 10 % glycerol and 0.02 % sodium azide. TRAIL-R1 is a receptor for the cytotoxic ligand TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappaB.

    Purification

    Purified from concentrated hybridoma tissue culture supernatant.

    Purity

    >95 % (SDS-PAGE)

    Immunogen

    Recombinant human TRAIL-R1 (DR4).

    Isotype

    IgG2b
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Specially developed for the immunohistochemical detection of TRAIL-R1 in paraffin embedded tissue. Has been shown to detect TRAIL-R1 expressed at endogenous levels in paraffin-embedded tissue in different mammary carcinoma tissues.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    In PBS containing 10 % glycerol and 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Storage

    4 °C,-20 °C

    Storage Comment

    +4°C

    -20°C

    Stable for at least 1 year after receipt when stored at -20°C.

    Expiry Date

    12 months
  • Target

    TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))

    Alternative Name

    TRAIL-R1

    Background

    Alternate Names/Synonyms: TRAIL Receptor 1, DR4, APO2, TNFRSF10A, CD261

    Product Description: TRAIL-R1 is a receptor for the cytotoxic ligand TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappaB.

    UniProt

    O00220

    Pathways

    Apoptosis, Positive Regulation of Endopeptidase Activity
You are here:
Chat with us!